UTERINE SEROUS CARCINOMA
Clinical trials for UTERINE SEROUS CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UTERINE SEROUS CARCINOMA trials appear
Sign up with your email to follow new studies for UTERINE SEROUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental pill, VLS-1488, in people with advanced solid tumors that have not responded to other treatments. The drug works by blocking a protein that helps cancer cells divide. The trial has two parts: first finding a safe dose, then checking if it shrinks …
Matched conditions: UTERINE SEROUS CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Volastra Therapeutics, Inc. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New hope for rare uterine cancer: targeted drug trial launches
Disease control Recruiting nowThis study tests a drug called azenosertib in 25 women whose uterine serous carcinoma has come back or not gone away. The drug blocks a protein (Wee1) that cancer cells need to grow. Researchers will check if the drug slows tumor growth and look at how it affects cancer cells in …
Matched conditions: UTERINE SEROUS CARCINOMA
Phase: PHASE2 • Sponsor: Joyce Liu, MD • Aim: Disease control
Last updated May 12, 2026 13:40 UTC